![Vaccine preventable diseases (Topic 3) 12 MB](http://s1.studyres.com/store/data/003984279_1-3969d482e5d2c5ce8a78fa809ecce113-300x300.png)
Vaccine preventable diseases (Topic 3) 12 MB
... months (1999) with catch up in young adults but for infants, protection waned rapidly • In 2006 additional dose given at 12 months to extend protection • Changing epidemiology of MenW = replace MenC with ...
... months (1999) with catch up in young adults but for infants, protection waned rapidly • In 2006 additional dose given at 12 months to extend protection • Changing epidemiology of MenW = replace MenC with ...
Lymphadenopathy in Children
... • This disease result in the destruction of motor neurons caused by the poliovirus. • Polio is causes by a virus that attacks the nerve cells of the brain & spinal cord although not all infections result in severe injuries and paralysis. ...
... • This disease result in the destruction of motor neurons caused by the poliovirus. • Polio is causes by a virus that attacks the nerve cells of the brain & spinal cord although not all infections result in severe injuries and paralysis. ...
... indicated a statement from the Directorate of Health, which states however, "the return to an average stable endemic condition has not yet been reached. The epidemic is not over yet." From the beginning of the epidemic until 11 October [2009], 2531 dengue cases have been laboratory confirmed. For [t ...
Adacel Quadra - SA Pharmaceutical Journal
... A new combination vaccine for use as booster in children from 6 years of age, adolescents and adults There has been a resurgence in the incidence of pertussis in several countries. There has also been a shift in the age distribution of pertussis, with dramatic increases being reported among adolesce ...
... A new combination vaccine for use as booster in children from 6 years of age, adolescents and adults There has been a resurgence in the incidence of pertussis in several countries. There has also been a shift in the age distribution of pertussis, with dramatic increases being reported among adolesce ...
Prophylaxis of infectious diseases in children, specific and non
... 4. The Child has recovered from diphtheria of the pharynx. How to immunize this child against diphtheria later? А. Vaccination should be done through 6 months after the disease B. Vaccination should not be done C. Vaccination should be done by antidiphtherial serum D. Vaccination should be done to c ...
... 4. The Child has recovered from diphtheria of the pharynx. How to immunize this child against diphtheria later? А. Vaccination should be done through 6 months after the disease B. Vaccination should not be done C. Vaccination should be done by antidiphtherial serum D. Vaccination should be done to c ...
Nervous System Infections - Biology Online Learning
... • Enter body orally • Virus infects the throat and intestinal tract • Then moves to bloodstream ...
... • Enter body orally • Virus infects the throat and intestinal tract • Then moves to bloodstream ...
Active Immunization
... Indications for PASSIVE Immunization • Active immunization unavailable or contraindicated • Immunodeficient persons • High likelihood of exposure • No time for active immunity to develop • When disease is present, to ameliorate or aid in suppression of toxin effects or inflammatory response ...
... Indications for PASSIVE Immunization • Active immunization unavailable or contraindicated • Immunodeficient persons • High likelihood of exposure • No time for active immunity to develop • When disease is present, to ameliorate or aid in suppression of toxin effects or inflammatory response ...
Vaccine discovery and translation of new vaccine technology
... numerous other diseases, primarily those caused by bacterial infection. Other types of new vaccines that are conceptually similar include nucleic acid (DNA or RNA) products. These contain a gene coding for a protective antigen as well as sequences for expression in a mammalian host, thus turning the ...
... numerous other diseases, primarily those caused by bacterial infection. Other types of new vaccines that are conceptually similar include nucleic acid (DNA or RNA) products. These contain a gene coding for a protective antigen as well as sequences for expression in a mammalian host, thus turning the ...
virus - Angelfire
... ● acute generalized disease characterized by destruction of the motor cells in the spinal cord and brainstem, resulting to flaccid paralysis of the muscles innervated by the affected neurons ● highly communicable disease ● may occur in sporadic, endemic or epidemic form at any time of the year ma ...
... ● acute generalized disease characterized by destruction of the motor cells in the spinal cord and brainstem, resulting to flaccid paralysis of the muscles innervated by the affected neurons ● highly communicable disease ● may occur in sporadic, endemic or epidemic form at any time of the year ma ...
Ebola Vaccine Is the First to Block Infection
... promise in 2015. Now, a new report published in the journal Lancet provides even more encouraging results that suggest it may be the first vaccine to prevent infection with Ebola. The trial involved more than 11,000 people living in Guinea, one of the West African countries that bore the brunt of th ...
... promise in 2015. Now, a new report published in the journal Lancet provides even more encouraging results that suggest it may be the first vaccine to prevent infection with Ebola. The trial involved more than 11,000 people living in Guinea, one of the West African countries that bore the brunt of th ...
A Critical Look at 2015 Acute Flaccid Paralysis (AFP) Surveillance
... Abstract: Background: Poliomyelitis, a disease that predominantly affects children under the age of five years, is a highly infectious viral disease transmitted through the faeco-oral route. The disease could result in irreversible paralysis in 1:200 infections and has a case fatality rate of 5-10% ...
... Abstract: Background: Poliomyelitis, a disease that predominantly affects children under the age of five years, is a highly infectious viral disease transmitted through the faeco-oral route. The disease could result in irreversible paralysis in 1:200 infections and has a case fatality rate of 5-10% ...
1.what is the magnitude of the effect a delay has on tranmission 2
... Influenza Vaccination Strategies when supply is limited ...
... Influenza Vaccination Strategies when supply is limited ...
PDF printable version of Appendix 5: Glossary of technical terms of
... other industrialised countries is DTPa, which contains an acellular pertussis component made of refined pertussis extracts instead of inactivated whole pertussis bacteria (DTPw). The acronym DTPa, using capital letters, signifies child formulations of diphtheria, tetanus and acellular pertussis-cont ...
... other industrialised countries is DTPa, which contains an acellular pertussis component made of refined pertussis extracts instead of inactivated whole pertussis bacteria (DTPw). The acronym DTPa, using capital letters, signifies child formulations of diphtheria, tetanus and acellular pertussis-cont ...
RNA Viruses - GEOCITIES.ws
... main groups based on resistance to ph between 3-5 and habitat. 1st group is rhino viruses, 2nd group is enteroviruses. Note that enteroviruses do not cause gastroenteritis. The former has more than 100 serotypes, which cause common cold infections, upper and lower respiratory tract infections and br ...
... main groups based on resistance to ph between 3-5 and habitat. 1st group is rhino viruses, 2nd group is enteroviruses. Note that enteroviruses do not cause gastroenteritis. The former has more than 100 serotypes, which cause common cold infections, upper and lower respiratory tract infections and br ...
Keep our children healthy and our schools disease-free
... Check with your health care provider or local public health unit to make sure the immunization schedule, no further vaccines will be needed. Did you know that it’s your responsibility to report your child’s updated immunization records to your local public health unit? Your health care provider does ...
... Check with your health care provider or local public health unit to make sure the immunization schedule, no further vaccines will be needed. Did you know that it’s your responsibility to report your child’s updated immunization records to your local public health unit? Your health care provider does ...
Serology: Screening for Vaccine Preventable Diseases
... • Active vaccination is induction of host immune response by administration of antigen – long lasting - years. • Passive vaccination is provision of antibody which provides protective immunity over a relatively short period – weeks to months. ...
... • Active vaccination is induction of host immune response by administration of antigen – long lasting - years. • Passive vaccination is provision of antibody which provides protective immunity over a relatively short period – weeks to months. ...
Get cached PDF
... observation that the disease was transmitted primarily through subclinical infections, no tests for the presence of poliovirus could be developed; and although Simon Flexner had pronounced the source of infection to lie in the nasopharynx, precautions taken on this assumption had demonstrably little ...
... observation that the disease was transmitted primarily through subclinical infections, no tests for the presence of poliovirus could be developed; and although Simon Flexner had pronounced the source of infection to lie in the nasopharynx, precautions taken on this assumption had demonstrably little ...
Eurosurveillance Weekly, funded by Directorate General Health and
... sampled. Six (3%) of the isolates were resistant to chloramphenicol or tetracycline, and four (2%) to methicillin. Haemophilus spp. were isolated from 369 (72%) of 513 samples, and 63 (17%) of the 369 were resistant to ampicillin, 49 (13%) to erythromycin, and seven (2%) to tetracycline. Branhamella ...
... sampled. Six (3%) of the isolates were resistant to chloramphenicol or tetracycline, and four (2%) to methicillin. Haemophilus spp. were isolated from 369 (72%) of 513 samples, and 63 (17%) of the 369 were resistant to ampicillin, 49 (13%) to erythromycin, and seven (2%) to tetracycline. Branhamella ...
Children from Birth through 6 Years Old
... T wo doses of HepA vaccine are needed for lasting protection. The first dose of HepA vaccine should be given between 12 months and 23 months of age. The second dose should be given 6 to 18 months later. HepA vaccination may be given to any child 12 months and older to protect against HepA. Childr ...
... T wo doses of HepA vaccine are needed for lasting protection. The first dose of HepA vaccine should be given between 12 months and 23 months of age. The second dose should be given 6 to 18 months later. HepA vaccination may be given to any child 12 months and older to protect against HepA. Childr ...
considerations for the timing of a single dose of ipv in the routine
... associated with subsequent doses of OPV, with the age distribution concentrated among 1-4 year old children [20]. This difference in epidemiology most likely reflects the low immunogenicity of OPV in some tropical developing countries [4-6], which delays the actual immunizing dose to later in life [ ...
... associated with subsequent doses of OPV, with the age distribution concentrated among 1-4 year old children [20]. This difference in epidemiology most likely reflects the low immunogenicity of OPV in some tropical developing countries [4-6], which delays the actual immunizing dose to later in life [ ...
Bovi-Shield BRSV
... by bovine respiratory syncytial virus (BRSV). Bovi-Shield BRSV is a freezedried preparation of an attenuated strain of BRSV propagated on an estab lished bovine cell line, plus a sterile diluent used to rehydrate the freezedried vaccine. DISEASE DESCRIPTION: BRSV is the etiologic agent of a spec ...
... by bovine respiratory syncytial virus (BRSV). Bovi-Shield BRSV is a freezedried preparation of an attenuated strain of BRSV propagated on an estab lished bovine cell line, plus a sterile diluent used to rehydrate the freezedried vaccine. DISEASE DESCRIPTION: BRSV is the etiologic agent of a spec ...
Virus
... infection on clinical grounds. However, in the following epidemic situations, echoviruses must be considered: (1) summer outbreaks of aseptic meningitis; (2) summer epidemics, especially in young children, of a febrile illness with rash; and (3) outbreaks of diarrheal disease in young infants from w ...
... infection on clinical grounds. However, in the following epidemic situations, echoviruses must be considered: (1) summer outbreaks of aseptic meningitis; (2) summer epidemics, especially in young children, of a febrile illness with rash; and (3) outbreaks of diarrheal disease in young infants from w ...
School Immunization Checklist
... from many serious diseases that are easily spread in schools. Under the Immunization of School Pupils Act, children need to have proof of immunization against diphtheria, tetanus, polio, measles, mumps, rubella, meningococcal disease, whooping cough, and – for children born in 2010 or later – chicke ...
... from many serious diseases that are easily spread in schools. Under the Immunization of School Pupils Act, children need to have proof of immunization against diphtheria, tetanus, polio, measles, mumps, rubella, meningococcal disease, whooping cough, and – for children born in 2010 or later – chicke ...
Poliomyelitis
![](https://commons.wikimedia.org/wiki/Special:FilePath/Polio_lores134.jpg?width=300)
Poliomyelitis, often called polio or infantile paralysis, is an infectious disease caused by the poliovirus. Approximately 90% to 95% of infections cause no symptoms. Another 5 to 10% of people have minor symptoms such as: fever, headache, vomiting, diarrhea, neck stiffness and pains in the arms and legs. These people are usually back to normal within one or two weeks. In about 0.5% of cases there is muscle weakness resulting in an inability to move. This can occur over a few hours to few days. The weakness most often involves the legs but may less commonly involve the muscles of the head, neck and diaphragm. Many but not all people fully recover. In those with muscle weakness about 2% to 5% of children and 15% to 30% of adults die. Years after recovery post-polio syndrome may occur, with a slow development of muscle weakness similar to what the person had during the initial infection.Poliovirus is usually spread from person to person through infected feces entering the mouth. It may also be spread by food or water containing human feces and less commonly from infected saliva. Those who are infected may spread the disease even if no symptoms are present for up to six weeks. The disease may be diagnosed by finding the virus in the feces or detecting antibodies against it in the blood.The disease is preventable with the polio vaccine; however, a number of doses are required for it to be effective. The United States Center for Disease Control recommends polio vaccination boosters for travelers and those who live in countries where the disease is occurring. Once infected there is no specific treatment. In 2013 polio affected 416 people down from 350,000 cases in 1988. In 2014 the disease was only spreading between people in Afghanistan, Nigeria, and Pakistan. In 2015 wild polio was eliminated in Nigeria.Poliomyelitis has existed for thousands of years, with depictions of the disease in ancient art. The disease was first recognized as a distinct condition by Michael Underwood in 1789 and the virus that causes it was first identified in 1908 by Karl Landsteiner. Major outbreaks started to occur in the late 19th century in Europe and the United States. In the 20th century it became one of the most worrying childhood diseases in these areas. The first polio vaccine was developed in the 1950s by Jonas Salk. It is hoped that vaccination efforts and early detection of cases will result in global eradication of the disease by 2018. In 2013; however, there were reports of new cases in Syria and in May 2014, the World Health Organization declared a public health emergency of international concern due to outbreaks of the disease in Asia, Africa and the Middle East. The disease does not naturally occur in any other animals.